Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumabMaki Yoshino, Toshio Takagi, Hironori Fukuda et al.|Japanese Journal of Clinical Oncology|2022Cited by 16
High real-world incidence of hepatic dysfunction from cabozantinib plus nivolumab for Japanese patients with metastatic renal cell carcinomaToshihide Horiuchi, Koichi Nishimura, Kazutaka Nakamura et al.|Japanese Journal of Clinical Oncology|2025Cited by 1
Efficacy and safety of nivolumab plus cabozantinib in octogenarian patients with advanced renal cell carcinomaYuki Nemoto, Tsunenori Kondo, Takanori Endo et al.|Research Square|2024Cited by 0
Efficacy and safety of nivolumab plus cabozantinib in octogenarian patients with advanced renal cell carcinomaYuki Nemoto, Takanori Endo, Hogara Segawa et al.|International Urology and Nephrology|2025Cited by 0